Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
about
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancyEmerging patterns of somatic mutations in cancerCohesin mutations in myeloid malignancies: underlying mechanismsSciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionMDS prognostic scoring systems – past, present, and futureAge-related clonal hematopoiesis associated with adverse outcomesAge-related mutations associated with clonal hematopoietic expansion and malignanciesMolecular Testing in Patients with Suspected Myelodysplastic Syndromes.Germline ETV6 mutations and predisposition to hematological malignancies.Clinical and genetic predictors of prognosis in myelodysplastic syndromes.The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaThe challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failureClonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing.The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationTET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patientsPRPF8 defects cause missplicing in myeloid malignancies.Clonal evolution in myelodysplastic syndromesRecurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAcute myeloid leukemia ontogeny is defined by distinct somatic mutations.Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells.U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicingRole of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies.Mutational spectrum of adult T-ALLPeripheral blood mononuclear cell proteome changes in patients with myelodysplastic syndromeMutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic SyndromeKnockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells.CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseClinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents.Somatic SETBP1 mutations in myeloid malignanciesShort telomere length and its correlation with gene mutations in myelodysplastic syndrome.Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS).Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia.Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommonPeripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.Clinical and biological implications of driver mutations in myelodysplastic syndromes.
P2860
Q24314163-B29C7012-BA8D-43F4-B902-58910805F548Q27014126-097DCD14-0B88-4DE2-9AAB-346B8DE8434FQ27022740-6D6077C6-C6A6-40DB-8B21-A5C571B7D843Q27321859-8BACF6FB-EF13-4311-A554-DA8BE8D2642BQ28082460-2B6B2421-2707-4314-AD21-C104097DB6E4Q28386602-52D733E9-4561-4501-A160-2768FC6DC2CCQ28387160-639E8B96-DA21-45DF-818F-6BB7CC4A48D1Q33435980-D7D26FE2-FE62-426B-9961-FC95CC2086EBQ33442207-8B9CB025-D58D-4665-B23D-80D69DE00445Q33695906-01F9E5B7-E508-45AF-BB50-FB3C8862CDB1Q33796552-3AEE6A3E-5919-4898-9E78-B4C409EC1835Q33829778-6DBDB3EF-709B-40A5-9A1E-89CDCB61F42DQ33881155-23A2EAD4-9120-40F9-8134-4D414F9F249EQ33881163-E1C17FA6-2504-4978-8FC2-88F79200DE2EQ34396189-1902D6AD-8A99-40D1-B300-8E0F8220D75BQ34398397-A2CDC19E-2106-4E35-A0CC-56283837410AQ34429362-4C1AE4E9-5BF8-4728-A661-5DEFBDB6AB5BQ34555597-023182DF-730D-414E-B416-8138C76E1C58Q34655449-A3701ADB-216E-4E0C-85DD-36383DE1CCAEQ34893087-4BAF5A68-1D18-4985-BBDE-4A6DC7820D78Q35126237-197327B5-C05C-43CD-AC9E-E43B74118D5BQ35220373-5F29E61A-E0A4-4098-A965-1871C3C23F8BQ35348356-F47A5152-A47A-4DF4-81E0-A9ECEC0AC605Q35486110-E50D0904-6405-427D-A9D5-533C1557A20DQ35538419-92638F7B-14B2-4516-805E-E2FC964E4CDCQ35550090-2E40D39A-286B-4F2F-930E-ED9DAD03F402Q35556586-AAE07DE0-E200-468B-AFD0-F79FA26E6323Q35604082-05582622-CA22-4056-8A5D-41F33BA59C40Q35917455-F4DE9EDD-7184-48BE-BCEB-7E4C544EAF4AQ36185741-1F4A1ED8-CCD0-494F-812D-FEB5E3CD0209Q36274044-1B43053C-1AB5-470B-8DC8-0324D24FACDBQ36608689-3C7D8D1C-3007-44C3-A389-F82D0432C6E7Q37046564-E9DC43C3-7EEB-4D71-829B-3BDFB8B3F5BCQ37060418-E1BFF72D-6A3F-417B-8EAA-8B8380CB06F7Q37133403-76F2295D-6B09-4EBB-AF40-777DD4F52BEAQ37169115-53AFDA4C-C4E6-4687-ACD5-45A588882987Q37191355-427B09F1-A7D5-425E-B3CE-BAC2C17CEF1CQ37226756-8B64F96F-22F8-4BC3-8BE6-828E14968930Q37252302-3418CB98-8413-494C-9788-D2330F3C5369Q37334716-5B38FC06-D8C2-469B-8D9A-EE0A74F8BC59
P2860
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
@en
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
@nl
type
label
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
@en
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
@nl
prefLabel
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
@en
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.
@nl
P2093
P2860
P356
P1433
P1476
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
@en
P2093
C A Miller
J F DiPersio
P2860
P2888
P304
P356
10.1038/LEU.2013.58
P577
2013-02-27T00:00:00Z